Lars Wallentin Selected Research

pro-brain natriuretic peptide (1-76)

6/2022	Effects of early myocardial reperfusion and perfusion on myocardial necrosis/dysfunction and inflammation in patients with ST-segment and non-ST-segment elevation acute coronary syndrome: results from the PLATelet inhibition and patients Outcomes (PLATO) trial.
1/2022	Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
1/2022	Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
1/2021	Risk markers of incident atrial fibrillation in patients with coronary heart disease.
12/2020	Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
11/2020	Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation.
12/2019	Interleukin-18 in patients with acute coronary syndromes.
1/2019	Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes.
12/2018	Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
10/2018	Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars Wallentin Research Topics

Disease

180	Stroke (Strokes) 01/2022 - 05/2004
178	Hemorrhage 01/2022 - 05/2002
166	Acute Coronary Syndrome 06/2022 - 06/2002
160	Myocardial Infarction 06/2022 - 02/2002
141	Atrial Fibrillation 01/2022 - 05/2003
62	Embolism (Embolus) 01/2022 - 09/2009
51	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 05/2002
41	Thrombosis (Thrombus) 01/2021 - 05/2002
31	ST Elevation Myocardial Infarction 06/2022 - 04/2003
31	Heart Failure 01/2022 - 06/2002
28	Inflammation (Inflammations) 06/2022 - 12/2003
25	Coronary Disease (Coronary Heart Disease) 01/2022 - 05/2002
23	Atherosclerotic Plaque (Atheroma) 01/2022 - 05/2002
21	Cardiovascular Diseases (Cardiovascular Disease) 12/2021 - 06/2003
17	Ischemia 12/2020 - 07/2003
15	Diabetes Mellitus 01/2021 - 06/2002
15	Heart Diseases (Heart Disease) 11/2018 - 04/2007
12	Unstable Angina 01/2013 - 05/2002
11	Chronic Renal Insufficiency 12/2021 - 09/2010
11	Ischemic Stroke 12/2020 - 03/2010
11	Transient Ischemic Attack 04/2019 - 02/2010
9	Hypertension (High Blood Pressure) 01/2022 - 02/2010
9	Infarction (Infarctions) 01/2019 - 02/2002
9	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2018 - 05/2006
8	Obesity 12/2019 - 08/2013
8	Non-ST Elevated Myocardial Infarction 09/2019 - 11/2007
7	Necrosis 06/2022 - 12/2003
7	Hemorrhagic Stroke 01/2020 - 09/2009
7	Body Weight (Weight, Body) 01/2019 - 07/2003
6	Atherosclerosis 01/2021 - 02/2012
6	Neoplasms (Cancer) 12/2017 - 03/2010
5	Infections 01/2022 - 10/2012
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 02/2014
4	Thromboembolism 01/2021 - 03/2015
4	Sudden Death 10/2018 - 10/2012
4	Death (Near-Death Experience) 02/2015 - 02/2012
3	COVID-19 01/2022 - 11/2020
3	Renal Insufficiency (Renal Failure) 01/2022 - 09/2009
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2013

Drug/Important Bio-Agent (IBA)

103	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 05/2003
86	apixabanIBA 01/2022 - 06/2009
74	Clopidogrel (Plavix)FDA Link 04/2022 - 05/2003
69	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2003
67	TicagrelorIBA 04/2022 - 04/2009
42	AnticoagulantsIBA 01/2022 - 05/2003
41	Dabigatran FDA Link 01/2020 - 11/2007
40	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 02/2002
37	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2022 - 07/2003
33	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 07/2003
32	Growth Differentiation Factor 15IBA 06/2022 - 02/2007
27	Troponin T (Troponin T1)IBA 06/2022 - 05/2002
23	darapladibIBA 01/2022 - 10/2010
23	TroponinIBA 01/2021 - 05/2002
22	CreatinineIBA 01/2022 - 06/2002
21	C-Reactive ProteinIBA 06/2022 - 03/2003
20	Cystatin CIBA 01/2022 - 10/2004
19	Dalteparin (Dalteparin Sodium)FDA Link 02/2012 - 05/2002
18	Thrombin Receptors (Thrombin Receptor)IBA 01/2022 - 01/2012
17	vorapaxarIBA 12/2018 - 01/2012
16	Vitamin K FDA Link 01/2022 - 05/2009
16	Heparin (Liquaemin)FDA LinkGeneric 09/2019 - 02/2002
15	Interleukin-6 (Interleukin 6)IBA 06/2022 - 12/2003
13	Troponin IIBA 01/2021 - 06/2003
13	Pharmaceutical PreparationsIBA 01/2021 - 05/2003
13	Prasugrel Hydrochloride FDA Link 01/2020 - 05/2006
11	Glycoproteins (Glycoprotein)IBA 09/2019 - 10/2002
11	Enoxaparin (Lovenox)FDA LinkGeneric 02/2010 - 08/2003
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
9	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2022 - 03/2006
9	Fondaparinux (Arixtra)FDA Link 02/2015 - 12/2005
8	Thrombin FDA Link 01/2020 - 05/2002
8	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2016 - 05/2002
7	LDL CholesterolIBA 01/2020 - 03/2006
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 08/2006
7	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2015 - 05/2002
6	Trinitrotoluene (TNT)IBA 06/2022 - 03/2003
6	omega-Chloroacetophenone (Mace)IBA 01/2022 - 10/2010
6	Natriuretic PeptidesIBA 11/2021 - 09/2004
6	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2015 - 05/2004
6	Tenecteplase FDA Link 10/2006 - 08/2003
6	Abciximab (ReoPro)FDA Link 10/2006 - 08/2003
5	Triglycerides (Triacylglycerol)IBA 01/2022 - 03/2006
5	AntithrombinsIBA 11/2011 - 02/2004
5	Factor Xa InhibitorsIBA 09/2011 - 12/2005
4	Cytochrome P-450 CYP2C19IBA 01/2021 - 07/2009
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2020 - 01/2017
4	LDL Lipoproteins (beta Lipoproteins)IBA 11/2019 - 03/2006
4	fibrin fragment D (D-dimer)IBA 01/2017 - 02/2002
4	MetalsIBA 09/2014 - 03/2007
3	RivaroxabanIBA 01/2022 - 04/2012
3	factor V LeidenIBA 01/2021 - 11/2020

Therapy/Procedure

132	Therapeutics 01/2022 - 02/2002
32	Percutaneous Coronary Intervention 06/2022 - 10/2002
27	Stents 01/2021 - 03/2007
17	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 05/2004
10	Critical Care (Surgical Intensive Care) 11/2013 - 10/2004
9	Patient Readmission 03/2017 - 07/2008
7	Secondary Prevention 01/2021 - 08/2006
6	Conservative Treatment 09/2017 - 07/2008
4	Catheters 06/2015 - 10/2007